Omecamtiv mecarbil: a promising new drug in systolic heart failure

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	232-233
Number of pages	2
Journal	European Journal of Heart Failure
Volume	14
Issue number	3
DOIs	https://doi.org/10.1093/eurjhf/hfr178
Publication status	Published - 2012

Access to Document

@article{33f175306e23482380966ee38d20f63c,

title = "Omecamtiv mecarbil: a promising new drug in systolic heart failure",

author = "M.F.L. Meijs and F.W. Asselbergs and P.A.F.M. Doevendans",

year = "2012",

doi = "10.1093/eurjhf/hfr178",

language = "English",

volume = "14",

pages = "232--233",

journal = "European Journal of Heart Failure",

issn = "1388-9842",

publisher = "John Wiley \& Sons Inc.",

number = "3",

}

TY - JOUR

T1 - Omecamtiv mecarbil: a promising new drug in systolic heart failure

AU - Meijs, M.F.L.

AU - Asselbergs, F.W.

AU - Doevendans, P.A.F.M.

PY - 2012

Y1 - 2012

U2 - 10.1093/eurjhf/hfr178

DO - 10.1093/eurjhf/hfr178

M3 - Article

C2 - 22210833

SN - 1388-9842

VL - 14

SP - 232

EP - 233

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

IS - 3

ER -